GIGA has a broad expertise in the physiology and pharmacology of brainstem monoaminergic neurons, with a strong emphasis on midbrain dopaminergic neurons to understand this neurotransmitter system, with a possible outcome in terms of new therapeutic strategies for dopamine-dependent disorders.

Contact [] us to discuss how these capabilities can forward your projects! We will help you develop tailored solutions.